- Home
- DRMA vs BDRX Comparison
DRMA vs BDRX Comparison
Compare DRMA & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRMA
- BDRX
- Stock Information
- Founded
- DRMA 2014
- BDRX 2000
- Country
- DRMA United States
- BDRX United Kingdom
- Employees
- DRMA N/A
- BDRX N/A
- Industry
- DRMA Biotechnology: Pharmaceutical Preparations
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- DRMA Health Care
- BDRX Health Care
- Exchange
- DRMA Nasdaq
- BDRX Nasdaq
- Market Cap
- DRMA 2.2M
- BDRX 2.4M
- IPO Year
- DRMA 2021
- BDRX N/A
- Fundamental
- Price
- DRMA $1.33
- BDRX $4.28
- Analyst Decision
- DRMA Strong Buy
- BDRX Strong Buy
- Analyst Count
- DRMA 1
- BDRX 1
- Target Price
- DRMA $6.00
- BDRX $200.00
- AVG Volume (30 Days)
- DRMA 230.6K
- BDRX 16.1K
- Earning Date
- DRMA 11-13-2024
- BDRX 09-30-2024
- Dividend Yield
- DRMA N/A
- BDRX N/A
- EPS Growth
- DRMA N/A
- BDRX N/A
- EPS
- DRMA N/A
- BDRX N/A
- Revenue
- DRMA N/A
- BDRX $104,895.00
- Revenue This Year
- DRMA N/A
- BDRX N/A
- Revenue Next Year
- DRMA N/A
- BDRX N/A
- P/E Ratio
- DRMA N/A
- BDRX N/A
- Revenue Growth
- DRMA N/A
- BDRX N/A
- 52 Week Low
- DRMA $1.00
- BDRX $3.50
- 52 Week High
- DRMA $8.66
- BDRX $74.00
- Technical
- Relative Strength Index (RSI)
- DRMA 51.81
- BDRX 47.13
- Support Level
- DRMA $1.30
- BDRX $4.13
- Resistance Level
- DRMA $1.48
- BDRX $4.60
- Average True Range (ATR)
- DRMA 0.12
- BDRX 0.25
- MACD
- DRMA 0.00
- BDRX 0.04
- Stochastic Oscillator
- DRMA 49.66
- BDRX 55.15
About DRMA Dermata Therapeutics Inc.
Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.
About BDRX Biodexa Pharmaceuticals plc American Depositary Shs
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.